The Department of Cell Biology pursues the dual mission of advancing biomedical research and education. Our small yet highly interactive group of investigators is committed to training research scientists in cutting-edge biomedical approaches, as well as supporting the education of medical students in the basic science courses that form the foundation for their future learning and clinical studies.
Our faculty have diverse research interests including topics such as: the molecular biology of gene regulation and expression, cell cycle, aging and studies of neurodegenerative disease, cardiovascular disease and cancer. Research in the Department has been supported by the National Institutes of Health, the National Science Foundation, the American Heart Association, the Canavan Disease Foundation, the Department of Defense and other public and private organizations. Over the past few years our faculty have published articles in some of the most prestigious journals in our fields, including: Science, Nature, Proceedings of the National Academy of Sciences, Cell, and Shock.
The Department has over 17,000 square feet of research space in the Science Center. Of this, 12,000 square feet is devoted to individual investigator laboratories and offices and 5,000 square feet is devoted to common and shared facilities, classrooms, and conference rooms. Our core facilities include a number of specialized instruments such as laser capture microdissection and confocal microscopes, a Bruker MALDI-TOF mass spec for protein analysis, a KinTek stopped-flow apparatus for kinetic analyses, and molecular modeling graphic stations. For a more complete list of our resources, please contact the Department of Cell Biology Administration Office.
Our Faculty have developed technologies of potential commercial application, and have numerous patent applications or disclosures in such areas as molecular diagnostics, gene therapy, nanotechnology, and anti-inflammatory therapy. Located within the Department are the Gene Therapy Center and the Molecular Marker/Proteomic Facility. In recent years over 70% of patent activities from the SOM Campus have involved members of our faculty.
Our growing Department offers a high faculty-to-student ratio and welcomes new students to join us in an exciting atmosphere. Our mission includes a commitment to teaching medical school courses, a highly active doctoral program (including a Ph.D./DO track), and a number of Masters programs. We also invest in the future by hosting a Summer Undergraduate Research Experience (SURE) program for undergraduate students considering graduate education in the biomedical sciences.
- Molodtsov V, Anikin M, McAllister WT. The Presence of an RNA:DNA Hybrid That Is Prone to Slippage Promotes Termination by T7 RNA Polymerase. J Mol Biol, 426(18): 3095-107, September 2014.
- Kulikovsky A, Serebryakova M, Bantysh O, Metlitskaya A, Borukhov S, Severinov K, Dubiley S. The molecular mechanism of aminopropylation of peptide-nucleotide antibiotic microcin C. J Am Chem Soc, 136(31): 11168-75, August 2014.
- Markov DA, Wojtas ID, Tessitore K, Henderson S, McAllister WT. Yeast DEAD box protein Mss116p is a transcription elongation factor that modulates the activity of mitochondrial RNA polymerase. Mol Cell Biol, 34(13): 2360-9, July 2014.
- Morozov YI, Agaronyan K, Cheung AC, Anikin M, Cramer P, Temiakov D. A novel intermediate in transcription initiation by human mitochondrial RNA polymerase. Nucleic Acids Res, 42(6): 3884-93, April 2014.
Shcherbik N. Golgi-medicated glycosylation determines residency of the T2 RNase Rny1p in Saccharomyces cerevisiae. Traffic, 14(12): 1209-27, December 2013.
Faculty in the News
Science Daily - Dr. Leone
First Use of a Gene Therapy Shows Promise Against Fatal Childhood Disease
Gene Therapy Extends Lives of Children with Brain Diseases
News-Medical.net - Dr. TemiakovUMDNJ biochemist to research into mechanisms that control gene expression in mitochondria
- Science Daily - Dr. Nagele
- South Jersey Times - Drs. Venkataraman & Yin